Lexicon Pharmaceuticals Inc Lxrx Ceo Lonnel Coats On Q2 2018 Results Earnings Call Transcript | Latest News RSS feed

Lexicon Pharmaceuticals Inc Lxrx Ceo Lonnel Coats On Q2 2018 Results Earnings Call Transcript - Latest News


Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q2 2018 Results - Earnings Call Transcript

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q2 2018 Earnings Conference Call July 30, 2018 8:00 AM ET Executives Kimberly Lee - IR Lonnel Coats - President and CEO Praveen Tyle - EVP, Research and Dev... read more

Lexicon: 2Q Earnings Snapshot

THE WOODLANDS, Texas (AP) _ Lexicon Pharmaceuticals Inc. (LXRX) on Monday reported a loss of $34.7 million in its second quarter. On a per-share basis, the The Woodlands, Texas-based company said it h... read more

LEXICON PHARMACEUTICALS, INC. : Results of Operations and Financial Condition (form 8-K)

On July 30, 2018, we issued a press release to report our financial results for the three months ended June ... Exhibits Exhibit No. Description 99.1 - Press Release of Lexicon Pharmaceuticals, Inc. d... read more

Looking for another news?


Lexicon Pharmaceuticals to Present at Upcoming Investor Conference

THE WOODLANDS, Texas, May 01, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (LXRX) today announced that Lonnel Coats, President and Chief Executive ... to Lexicon’s growth and future operatin... read more

Jetpack

Lexicon Pharmaceuticals Reports Third Quarter 2017 Financial Results And Provides A Business Update

XERMELO® (telotristat ethyl) U.S. Quarterly Net Sales Reach $5.3 Million Conference Call and Webcast Today at 8:00 am EST / 7:00 am CST THE WOODLANDS, Texas , Nov. 8, 2017 /PRNewswire/ -- Lexicon Phar... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us